274 related articles for article (PubMed ID: 21957450)
1. Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.
Zamakhchari M; Wei G; Dewhirst F; Lee J; Schuppan D; Oppenheim FG; Helmerhorst EJ
PLoS One; 2011; 6(9):e24455. PubMed ID: 21957450
[TBL] [Abstract][Full Text] [Related]
2. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity.
Fernandez-Feo M; Wei G; Blumenkranz G; Dewhirst FE; Schuppan D; Oppenheim FG; Helmerhorst EJ
Clin Microbiol Infect; 2013 Sep; 19(9):E386-94. PubMed ID: 23714165
[TBL] [Abstract][Full Text] [Related]
3. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.
Tian N; Wei G; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G769-76. PubMed ID: 25147233
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG
PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997
[TBL] [Abstract][Full Text] [Related]
5. Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.
Wei G; Tian N; Siezen R; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G571-80. PubMed ID: 27469368
[TBL] [Abstract][Full Text] [Related]
6. Commensal Bacterium
Wei G; Darwish G; Oppenheim FG; Schuppan D; Helmerhorst EJ
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276655
[TBL] [Abstract][Full Text] [Related]
7. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
[TBL] [Abstract][Full Text] [Related]
8. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ
Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531
[TBL] [Abstract][Full Text] [Related]
9. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.
Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ
Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519
[TBL] [Abstract][Full Text] [Related]
10. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
[TBL] [Abstract][Full Text] [Related]
11. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.
Duar RM; Clark KJ; Patil PB; Hernández C; Brüning S; Burkey TE; Madayiputhiya N; Taylor SL; Walter J
J Appl Microbiol; 2015 Feb; 118(2):515-27. PubMed ID: 25376327
[TBL] [Abstract][Full Text] [Related]
13. Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements.
Janssen G; Christis C; Kooy-Winkelaar Y; Edens L; Smith D; van Veelen P; Koning F
PLoS One; 2015; 10(6):e0128065. PubMed ID: 26030273
[TBL] [Abstract][Full Text] [Related]
14. The Human Digestive Tract Is Capable of Degrading Gluten from Birth.
Fernández-Pérez S; Pérez-Andrés J; Gutiérrez S; Navasa N; Martínez-Blanco H; Ferrero MÁ; Vivas S; Vaquero L; Iglesias C; Casqueiro J; Rodríguez-Aparicio LB
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080976
[TBL] [Abstract][Full Text] [Related]
15. Selection of Gut-Resistant Bacteria and Construction of Microbial Consortia for Improving Gluten Digestion under Simulated Gastrointestinal Conditions.
De Angelis M; Siragusa S; Vacca M; Di Cagno R; Cristofori F; Schwarm M; Pelzer S; Flügel M; Speckmann B; Francavilla R; Gobbetti M
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808622
[TBL] [Abstract][Full Text] [Related]
16. Molecular and Structural Parallels between Gluten Pathogenic Peptides and Bacterial-Derived Proteins by Bioinformatics Analysis.
Vazquez DS; Schilbert HM; Dodero VI
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502187
[TBL] [Abstract][Full Text] [Related]
17. Gluten Degrading Enzymes for Treatment of Celiac Disease.
Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
[TBL] [Abstract][Full Text] [Related]
18. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
[TBL] [Abstract][Full Text] [Related]
19. Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.
Berger M; Sarantopoulos C; Ongchangco D; Sry J; Cesario T
Exp Biol Med (Maywood); 2015 Jul; 240(7):917-24. PubMed ID: 25519429
[TBL] [Abstract][Full Text] [Related]
20. Thin-Plate Superstructures of the Immunogenic 33-mer Gliadin Peptide.
Herrera MG; Amundarain MJ; Nicoletti F; Drechsler M; Costabel M; Gentili PL; Dodero VI
Chembiochem; 2022 Nov; 23(22):e202200552. PubMed ID: 36161684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
